NORML
MARCH 1, 2019
” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue.
Cannabis Law Report
FEBRUARY 10, 2022
Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
APRIL 8, 2020
As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. To date, however, the DEA has failed to either affirm or reject any of the more than 30 applications it has received. In 2007, the agency lost yet another lawsuit.
Cannabis Law Report
APRIL 8, 2022
Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Lyle Craker, Ph.D., MAPS Founder Rick Doblin, Ph.D.,
Meadow
JULY 13, 2018
we want everyone who did not have the opportunity to attend Meadowlands to have access to this content. Back in 2007, it said we don’t want anymore cannabis businesses and despite a general prohibition, we still had more cannabis businesses than any other location. So in L.A., we know you have a cap for 400 retail locations.
Cannabis Law Report
MARCH 25, 2019
The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 2003, 2004, 2007, 2008, Nov. 2003, 2004, 2007, 2008, Nov. 6059, 6074, 6075, 6077(a), (b), 6253, Nov.
The Joint Blog
JUNE 2, 2020
In 2007, he acknowledged that ending raids on medical marijuana users was necessary, but that he believed that “there’s got to be a better answer than marijuana” for addressing health issues and symptoms. Only marijuana-friendly people will be assigned to DEA, DOJ, and FDA to get involved in the legalization process. Tulsi Gabbard Rep.
Expert insights. Personalized for you.
164 
Let's personalize your content